Emily Y. Ye

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Ariadne Diagnostics (United States)(Current)

Emily Y. Ye is an author at Ariadne Diagnostics (United States) specializing in molecular oncology, non-small cell lung cancer treatment, and non-small cell lung cancer therapy.

Publications per year

2015–2016

Publications

Abstract 2644: AP32788, a potent, selective inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, in preclinical models

Francois Gonzalvez, Xiaotian Zhu, Wei‐Sheng Huang et al. · Cancer Research · 2016 · 29 citations

Medicine, Oncology, Pharmacology +17

Abstract 781: The potent ALK inhibitor AP26113 can overcome mechanisms of resistance to first- and second-generation ALK TKIs in preclinical models

Sen Zhang, Sara Nadworny, Scott Wardwell et al. · Cancer Research · 2015 · 10 citations

Medicine, Oncology, Pharmacology +15

1–2 of 2